Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Saye Khoo, Ján Dixon, Geoffrey Saunders et al.|The Lancet Infectious Diseases|2022

Cited by 81